About Shandong Lukang Pharmaceutical Company

The company is a state-owned comprehensive pharmaceutical enterprise, founded in 1966 and listed on the main board of the Shanghai Stock Exchange in 1997 (stock code: 600789). In 2006, Lukang Pharmaceutical was owned by Hualu Holding Group Co., Ltd. Hualu Group was incorporated in Hong Kong in 1985. It focuses on the three major businesses of high-end chemicals, biomedicine, and ecological protection, and actually controls 3 listed companies, 4 stocks, and 5 unlisted companies including the Provincial Academy of Environmental Sciences and Hong Kong Hualu. It owns 63 companies, employs 18,000 people, and has total assets of 51 billion yuan. The company belongs to the pharmaceutical manufacturing industry and is mainly engaged in R&D, production and sales of pharmaceutical products. The company's products include antibiotics, amino acids, cardiovascular, antiviral, digestive, endocrine, respiratory, semi-synthetic antibiotic raw materials, biopharmaceuticals, and related preparations, infusions, proprietary Chinese medicines, pharmaceutical intermediates, antibiotics for animal health, starch, glucose, etc. The products cover more than 500 product standards such as capsules, tablets, dispersible tablets, powder injections, granules, dry suspensions, water injections, premixes, compound preparations, etc. Corporate honors: National High-tech Enterprise; Premium Credit Enterprise; National Enterprise Technology Center; AAA Credit Enterprise with Enterprise Credit Evaluation, China's Top 100 Pharmaceutical Industry Enterprises, High-end Brands in Shandong Manufacturing Industry, Advanced Energy Saving and Consumption Reduction Enterprise, etc., which have won honorary titles such as National Advanced Quality and Efficiency Enterprise and Model Enterprise for Pharmaceutical Quality and Integrity Construction.